Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GGT1 | P19440 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13990159 | 0.91 | L3MBTL1 (0.52) | ALDH1A1ALOX15TP53TDP1SMN1; SMN2 | |
| Phthalic Acid SCHEMBL28107851 | 0.86 | ALDH1A1 (0.70) | ALDH1A1ALOX15TDP1SMN1; SMN2AKR1C3 | |
| Phthalic Acid SCHEMBL122971 | 0.86 | ALDH1A1 (0.70) | ALDH1A1ALOX15TDP1SMN1; SMN2AKR1C3 | |
| Phthalic Acid SCHEMBL27458631 | 0.85 | ALDH1A1 (0.78) | ALDH1A1ALOX15TDP1SMN1; SMN2AKR1C3 | |
| SCHEMBL28738497 | 0.85 | MYC (0.52) | ALDH1A1ALOX15TDP1SMN1; SMN2MAPT | |
| Phthalic Acid SCHEMBL3030281 | 0.84 | ALDH1A1 (0.67) | ALDH1A1ALOX15TDP1SMN1; SMN2AKR1C3 | |
| Phthalic Acid SCHEMBL1482851 | 0.83 | ALDH1A1 (0.74) | ALDH1A1ALOX15TP53TDP1SMN1; SMN2 | |
| Phthalic Acid SCHEMBL10779822 | 0.83 | ALDH1A1 (0.74) | ALDH1A1ALOX15TDP1SMN1; SMN2AKR1C3 | |
| Phthalic Acid SCHEMBL9132518 | 0.83 | ALDH1A1 (0.74) | ALDH1A1ALOX15TP53TDP1SMN1; SMN2 | |
| SCHEMBL9533934 | 0.83 | ALDH1A1 (0.58) | ALDH1A1ALOX15USP2TP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104419326-A | Slurry composition for chemical mechanical polishing | COWON INNOTECH INC | 2015-03-18 | — | — | CN | claimed |
| CN-118619905-A | Butylphthalide derivative, preparation method and application thereof | 河南真实生物科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-218012756-U | 2-ethyl anthraquinone production system capable of reducing dissolution closed-loop acid consumption | 百色世裕科技股份有限公司 | 2022-12-13 | — | — | CN | disclosed |
| EP-3218009-B1 | PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG | POLYTHERICS LTD (GB) | 2021-04-07 | — | — | EP | disclosed |
| CN-107949596-B | Semi-crystalline polyamide component with high glass transition temperature for composite materials, method for the production thereof and use thereof | 阿科玛法国公司 | 2021-02-02 | — | — | CN | disclosed |
| CN-108026267-B | Semi-crystalline polyamide composition with high glass transition temperature for thermoplastic materials, method for the production thereof and use thereof | 阿科玛法国公司 | 2021-02-02 | — | — | CN | disclosed |
| US-10835616-B2 | Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of PEG | POLYTHERICS LIMITED (GB) | 2020-11-17 | — | — | US | disclosed |
| US-20180094010-A1 | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | NEWGEN THERAPEUTICS INC (US) | 2018-04-05 | — | — | US | disclosed |
| US-20180081273-A1 | RESIN COMPOSITION, METHOD FOR FORMING PATTERN USING THE SAME, AND METHOD FOR SYNTHESIZING POLYMER | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-03-22 | — | — | US | disclosed |
| US-20170363637-A1 | Method and Kit for Determining Risk of Preterm Birth and/or Birth of Low-Birth-Weight Baby | HIROSHIMA UNIVERSITY (JP) | 2017-12-21 | — | — | US | disclosed |
| US-5780634-A | Process for producing 2-(carboxyphenyl)-4-quinolinecarboxylic acid compounds | THE GREEN CROSS CORPORATION (JP) | 1998-07-14 | — | — | US | disclosed |
| EP-0709377-A1 | Process for producing quinolin-2-yl benzoic acid compounds | ASAHI GLASS COMPANY LTD. (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5264436-A | Alpha-adrenoceptors antagonist, hypotensive agents or antidiabetic agents | BEECHAM GROUP P.L.C. (GB) | 1993-11-23 | — | — | US | disclosed |
| EP-0275639-B1 | N-SUBSTITUTED CYCLIC AMIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1992-07-15 | — | — | EP | disclosed |
| US-5077299-A | Glaucoma, antidepressants, anticoagulants, hypotensive agents | BEECHAM GROUP P.L.C. (GB) | 1991-12-31 | — | — | US | disclosed |
| US-4918083-A | 4,5 Dihydroimidazole compounds which have useful pharmaceutical utility | BEECHAM GROUP P.L.C. (GB) | 1990-04-17 | — | — | US | disclosed |
| EP-0274906-A2 | Method for the production of crosslinked olefinic block copolymers | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1988-07-20 | — | — | EP | disclosed |
| US-4351842-A | N-Cyclopropylisoindolines | GLAXO LABORATORIES LIMITED (GB) | 1982-09-28 | — | — | US | disclosed |
| US-4058529-A | Polycyclic amino derivatives of pyrrolidone and piperidone | CIBA-GEIGY CORPORATION (US) | 1977-11-15 | — | — | US | disclosed |
| US-3994920-A | APPETITE SUPPRESSANT, ANTIDEPRESSANT | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170363637-A1 | Method and Kit for Determining Risk of Preterm Birth and/or Birth of Low-Birth-Weight Baby | LGALS3, LGALS3BP, LGALS1 | ALDH1A1 3283/4885ALOX15 2696/4885USP2 3220/4885 |
| US-10835616-B2 | Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of PEG | LNPEP, ANPEP, NGLY1 | ALDH1A1 3963/4885ALOX15 2780/4885USP2 125/4885 |
| US-20180094010-A1 | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | PARP1, PARP2, PARP11 | ALDH1A1 1069/4885ALOX15 441/4885USP2 3277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.